STRO · Sutro Biopharma Inc
United States · RS rating 9 · As of 2026-11-03
| Price | 9.51 USD |
|---|---|
| 1-day change | +4.4% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 8 / 5 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 21 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +20.8% |
| Sales growth Q/Q | +20.2% |
| Distance from 52-week high | +76.8% |
| Market cap (USD) | $577.1M |